Originally published at http://www.cancer.ucla.edu UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer Study shows the peptide enhances a […]
Study Explains Genetic Connection Between Aging and Cancer
David Gius, MD, PhD from Northwestern University was funded in the 2012 cycle of the Hirshberg Foundation’s annual Seed Grant Program. The results of the study explain the genetic connection […]
Hirshberg Funded International Researcher Publishes Findings
2011 Seed Grant Recipient Ido Wolf, MD from University of Tel Aviv, Israel, recently published his findings that will offer novel approaches towards development of new therapies for pancreatic cancer. […]
EPC Hirshberg Award Winners Announced
At the 48th meeting of the European Pancreatic Club, held this past June 8, 2016, in Liverpool, winners of the Hirshberg Awards were presented by one of the leading pancreatic […]
Seed Grant Recipient Receives Prestigious NIH Award
Dr. Timothy Frankel, MD, University of Michigan, has received the NIH Clinical Scientist Career Development Award. This award is a 5 year study totaling $875,000. The NIH funded project is […]
New Hope for Treating Pancreatic Cancer
Stephen Pandol, MD, and Mouad Edderkaoui, PhD, from Cedars-Sinai Medical Center have developed a novel drug, Metavert, to treat pancreatic cancer. The drug is designed to prevent metastasis of pancreatic […]